期刊文献+

双歧杆菌三联活菌散治疗感染性腹泻的疗效观察

Observation of efficacy of bifidobacterium triple viable power,lactobacillus and enterococcus powder in treatment of infectious diarrhea
暂未订购
导出
摘要 目的观察双歧杆菌三联活菌散对感染性腹泻患者疗效。方法选取2016年8月~2019年8月我院感染性腹泻患者258例为研究对象,随机分为常规治疗组(n=129)和常规治疗联合双歧杆菌三联活菌散治疗组(联合治疗组,n=129)两组,统计分析两组患者的临床疗效、症状消失时间。结果联合治疗组患者治疗总有效率为99.2%(128/129),显著高于常规治疗组的91.5%(118/129),差异有统计学意义(P<0.05)。联合治疗组患者脱水、呕吐、腹泻、发热消失时间均显著短于常规治疗组,差异有统计学意义(P<0.05)。结论双歧杆菌三联活菌散对感染性腹泻患者疗效显著,更能有效缩短患者的脱水、呕吐、腹泻、发热消失时间,值得在临床推广应用。 Objective To observe the efficacy of bifidobacterium,triple viable power in treatment of infectious diarrhea.Methods Two hundred and fifty-eight patients with infectious diarrhea in our hospital from August 2016 to August 2019 were selected as research subjects and randomly divided into two groups:the conventional treatment group(n=129)and the conventional treatment combined with live combined bifidobacterium,lactobacillus and enterococcus powder treatment group(the combined treatment group,n=129).The disappearance time of clinical effect and symptoms in the two groups was statistically analyzed.Results It was found that the overall response rate in the combined treatment group[99.2%,(128/129)]was significantly higher than that in the conventional treatment group[91.5%,(118/129)],with a statistically significant difference(P<0.05).The disappearance time of dehydration,vomiting,diarrhea and fever in the conventional treatment group was significantly shorter than that in the conventional treatment group,with a statistically significant difference(P<0.05).Conclusion Bifidobacterium triple viable power has significant efficacy in patients with infectious diarrhea,and can effectively shorten the disappearance time of dehydration,vomiting,diarrhea and fever,which is worthy of application in clinical experience.
作者 陈群 陈希 CHEN Qun;CHEN Xi(Department of Digestive System,the People's Hospital of Kaizhou District of Chongqing City,Chongqing405400,China;Department of Rheumatology and Immunology,the People's Hospital of Kaizhou District of Chongqing City,Chongqing405400,China)
出处 《中国现代医生》 2020年第4期98-100,共3页 China Modern Doctor
关键词 常规治疗 双歧杆菌三联活菌散 感染性腹泻 脱水 Conventional treatment Bifidobacterium triple viable power Infectious diarrhea Dehydration
  • 相关文献

参考文献13

二级参考文献75

  • 1刘秋蓓.双歧杆菌乳杆菌三联活菌片联合蒙脱石散治疗小儿腹泻的临床价值研究[J].医学信息,2017,30(20):83-84. 被引量:7
  • 2唐秋雨,林滨榕,吴斌,黄妙辉.小儿肺炎继发腹泻相关因素分析及微生态制剂的预防作用[J].中国实用儿科杂志,2005,20(12):732-734. 被引量:118
  • 3DuPont HL.Acute infectious diarrhea in immunocompetent a-dults[J].New Engl J Med,2014,370(16):1532-1540.
  • 4Farthing M,Salam MA,Lindberg G,et al.Acute diarrhea inadults and children:aglobal perspective[J].J Clin Gastroen-terol,2013,47(1):12-20.
  • 5Platts-Mills JA,Liu J,Houpt ER.New concepts in diagnos-tics for infectious diarrhea[J].Muc Immunol,2013,6(5):876-885.
  • 6Zhang Y,Zhao Y,Ding K,et al.Analysis of bacterial patho-gens causing acute diarrhea on the basis of sentinel surveil-lance in Shanghai,China,2006-2011[J].Jap J Infect Dis,2014,67(4):264-268.
  • 7Islek A,Sayar E,Yilmaz A,et al.The role of Bifidobacteri-um lactis B94plus inulin in the treatment of acute infectiousdiarrhea in children[J].Turk J Gastroenterol,2014,25(6):628-633.
  • 8Slavin J.Fiber and prebiotics:mechanisms and health benefits[J].Nutrients,2013,5(4):1417-1435.
  • 9Geurts L,Neyrinck AM,Delzenne NM,et al.Gut microbiota con-trols adipose tissue expansion,gut barrier and glucose metabo-lism:novel insights into molecular targets and interventions usingprebiotics[J].Benef Microbes,2013,5(1):3-17.
  • 10Lu X,Zeng S,Zhang Y,et al.Effects of water-soluble oligosaccha-rides extracted from lotus(Nelumbo nucifera Gaertn.)seeds ongrowth ability of Bifidobacterium adolescentis[J].Eur Food ResTechnol,2015,241(4):459-467.

共引文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部